Vibhavadi Medical Center Valuation
Is VIBHA-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VIBHA-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VIBHA-F (THB2.18) is trading above our estimate of fair value (THB1.39)
Significantly Below Fair Value: VIBHA-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VIBHA-F?
Other financial metrics that can be useful for relative valuation.
What is VIBHA-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿25.39b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.5x |
Enterprise Value/EBITDA | 20.6x |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does VIBHA-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.4x | ||
SKR Sikarin | 22.9x | n/a | ฿21.2b |
CHG Chularat Hospital | 30x | 13.9% | ฿32.6b |
RAM Ramkhamhaeng Hospital | 21.9x | 5.2% | ฿36.3b |
MASTER Master Style | 42.6x | 21.5% | ฿18.3b |
VIBHA-F Vibhavadi Medical Center | 30.4x | 19.2% | ฿25.4b |
Price-To-Earnings vs Peers: VIBHA-F is good value based on its Price-To-Earnings Ratio (30.4x) compared to the peer average (34.8x).
Price to Earnings Ratio vs Industry
How does VIBHA-F's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: VIBHA-F is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the TH Healthcare industry average (29.7x).
Price to Earnings Ratio vs Fair Ratio
What is VIBHA-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate VIBHA-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.